Nurix Therapeutics Information
Contact top employees from
Nurix Therapeutics
Summary
Nurix Therapeutics is a public company that has been in the industry for 16 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Arthur T. Sands. Its headquarters is located at San Francisco, California, USA. The number of employees ranges from 100 to 250. The annual revenue of Nurix Therapeutics varies between 5.0M and 25M. Total funding of the company - $545M. To connect with Nurix Therapeutics employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
200-500 employees
Specialties
research, life sciences, biotechnology
SIC Code
2836
DMA Code
San Francisco Bay Area
Founded
2012
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Contact Nurix Therapeutics
Organization Website
Social Links
Contact Email
ir@nurixtx.com
Phone Number
415-660-5320
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2007 | Public Company | 250 - 500 | 221.9M | $142.1M | |
| 2018 | Public Company | 25 - 100 | < 1M | $621.9M | |
| 2018 | Privately Held | 25 - 100 | 2.5M | $113.8M | |
| 2007 | Privately Held | 1 - 25 | 5.6M | $130.7M | |
| 2007 | Privately Held | 100 - 250 | 16M | $64.3M | |
| 2002 | Public Company | 250 - 500 | 341M | $580M | |
| 2017 | Privately Held | 25 - 100 | 4.5M | $73.3M | |
| 2016 | Public Company | 25 - 100 | 64.5M | $627.7M | |
| 2018 | Privately Held | 25 - 100 | 1.3M | $63M | |
| 2017 | Privately Held | 25 - 100 | < 1M | $521M | |
| 2005 | Privately Held | 1 - 25 | 3.5M | $150K | |
| 2001 | Public Company | 1 - 25 | 4.6M | $141.4M | |
| 2020 | - | 1 - 25 | < 1M | $50M | |
| 2018 | - | 25 - 100 | 5.6M | $81M | |
| 1976 | Public Company | 1.0K - 5.0K | 112.8M | $0 | |
| 2013 | - | 500-1000 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
Ex-employees switched to
Length of Employment
Employee tenure at Nurix Therapeutics shows a diverse range of experience levels:
5% have been with the company for less than 1 year44% for 1–2 years16% for 3–4 years15% for 5–7 years6% for 8–10 years12% have over 11 years of service at Nurix TherapeuticsEx-employees positions
In Company
In New Company
Contact top employees from
Nurix Therapeutics
Deborah Capes
Associate Director, Medical Writing
Anokha Ratnayake
Director Discovery Chemistry
Reena Nadpara
Senior Director, Regulatory Affairs Strategy
Sunny Patel
Senior Manager, FP&A
Nishi Shah
Chief Information Security Officer
Alejandro Amador
Executive Director
Andres Rojas PhD
Scientist II
James Iuliano
Scientist
Eunhee Kim
Senior Director, Biostatistics
Alexandra Borodovsky
Director
Jennifer Tung
Pharmacology Lab Manager
Anil Kapur
Board Member
Ganesh Cherala
Vice President (Clinical Pharmacology)
Amber Guillen
Senior Scientist - Analytical Chemistry
Sumit Prakash
Associate Director Project Team Lead
Caroline Davis
Scientist I, Discovery Biology
Parul Roo Vold
SVP Global Pharmacovigilance
Naincy Chandan
Scientist II
Valasani Koteswara Rao
Associate Director CMC Analytical Development and QC
Mirjana Zeremski
Clinical Development Consultant
Wylie Palmer
Executive Director
Jingjie Moore PHRca
Manager, Human Resources Operations
Lauren Goeser
Laboratory Automation Scientist II
Brandon Bravo
Principal Scientist
Geoffrey Yeh
Executive Director, Analytical Development and Quality Control
Kris Fortner
Senior Director, Corporate Communications and Investor Relations
Katherine Leon
Senior Scientist, DEL & Protein Sciences
Natasha Goodson
Clinical Program Manager
